We are live on ! Find out more
RHJA

Rice Hall James & Associates Portfolio holdings

AUM $1.8B
1-Year Est. Return 36.16%
This Fund
S&P 500
This Quarter Est. Return
-12.36%
1 Year Est. Return
+36.16%
3 Year Est. Return
+116.66%
5 Year Est. Return
+140.56%
10 Year Est. Return
+771.9%
AUM
$2.07B
AUM Growth
-$441M
Cap. Flow
-$81M
Cap. Flow %
-3.92%
Top 10 Hldgs %
24.52%
Holding
315
New
9
Increased
84
Reduced
155
Closed
50

Sector Composition

Rank Sector Weight
1 Technology 27.57%
2 Healthcare 25.36%
3 Industrials 14.78%
4 Consumer Discretionary 12.93%
5 Communication Services 6.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WNS
1
DELISTED
WNS Holdings
WNS
$65.7M 3.18%
880,136
-34,169
-4% -$2.61M
LRN icon
2
Stride
LRN
$3.47B
$59.5M 2.88%
1,458,357
-107,356
-7% -$3.98M
MED icon
3
Medifast
MED
$108M
$56.9M 2.75%
315,357
-10,682
-3% -$1.91M
ACIW icon
4
ACI Worldwide
ACIW
$5.81B
$50.3M 2.43%
1,941,838
-90,055
-4% -$2.42M
DOOR
5
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
$50.2M 2.43%
653,816
-21,316
-3% -$1.75M
EEFT icon
6
Euronet Worldwide
EEFT
$2.77B
$47.5M 2.29%
471,809
-26,264
-5% -$3.11M
ZD icon
7
Ziff Davis
ZD
$1.92B
$46.6M 2.25%
624,997
-33,376
-5% -$2.77M
WWE
8
DELISTED
World Wrestling Entertainment
WWE
$45.5M 2.2%
728,874
-38,756
-5% -$2.4M
PBH icon
9
Prestige Consumer Healthcare
PBH
$2.35B
$44M 2.13%
749,025
-19,672
-3% -$1.08M
SMTC icon
10
Semtech
SMTC
$11.1B
$40.9M 1.98%
743,203
-38,642
-5% -$2.33M
DFIN icon
11
Donnelley Financial Solutions
DFIN
$1.21B
$40.7M 1.97%
1,390,509
+11,376
+0.8% +$338K
PINC
12
DELISTED
Premier
PINC
$40.3M 1.95%
1,130,622
-58,025
-5% -$2.12M
BHVN
13
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$38.3M 1.85%
263,030
-13,976
-5% -$1.79M
LCII icon
14
LCI Industries
LCII
$2.46B
$36.2M 1.75%
323,900
-29,170
-8% -$3.19M
LGND icon
15
Ligand Pharmaceuticals
LGND
$5.83B
$29.9M 1.44%
536,431
-16,554
-3% -$939K
AX icon
16
Axos Financial
AX
$5.69B
$29.7M 1.44%
828,123
-31,007
-4% -$1.19M
NGVT icon
17
Ingevity
NGVT
$2.48B
$29.3M 1.42%
464,649
-23,197
-5% -$1.51M
SIMO icon
18
Silicon Motion
SIMO
$8.85B
$28.7M 1.39%
342,690
-312,409
-48% -$26.3M
APPS icon
19
Digital Turbine
APPS
$971M
$28.1M 1.36%
1,605,790
+1,114,347
+227% +$30.2M
MEDP icon
20
Medpace
MEDP
$16B
$28M 1.35%
187,145
+3,589
+2% +$520K
RDWR icon
21
Radware
RDWR
$1.07B
$26M 1.26%
1,198,585
-22,485
-2% -$589K
AWI icon
22
Armstrong World Industries
AWI
$7.31B
$25.8M 1.25%
344,010
-17,872
-5% -$1.51M
PCRX icon
23
Pacira BioSciences
PCRX
$1.04B
$24.7M 1.2%
424,080
-32,718
-7% -$2.14M
SUPN icon
24
Supernus Pharmaceuticals
SUPN
$2.6B
$24.1M 1.17%
833,952
-20,997
-2% -$601K
POOL icon
25
Pool Corp
POOL
$6.77B
$24.1M 1.17%
68,659
-5,221
-7% -$2.07M

Similar funds

Rice Hall James & Associates's Q2 2022 Portfolio in Review

As of Q2 2022, Rice Hall James & Associates held 315 positions worth $2.07B, down 18% from $2.51B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Rice Hall James & Associates withdrew a net $81M in Q2 2022, closing 50 positions and reducing 155 holdings. Its most notable exit was Mimecast Limited, an estimated $19.2M position sold in full.

By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 29% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Rice Hall James & Associates opened a new position in Albany International worth $4.99M.

  • Rice Hall James & Associates's largest Q2 2022 buy was Albany International: 63,306 shares worth $4.99M.
  • Rice Hall James & Associates added most to Digital Turbine in Q2 2022, an estimated $30.2M increase.
  • Rice Hall James & Associates's biggest Q2 2022 reduction was Silicon Motion, cutting an estimated $26.3M.
  • Rice Hall James & Associates fully exited Mimecast Limited in Q2 2022, selling an estimated $19.2M.
  • Rice Hall James & Associates's ten largest holdings make up 25% of its $2.07B portfolio in Q2 2022.
  • Rice Hall James & Associates opened 9 new positions and closed 50 in Q2 2022.
  • Rice Hall James & Associates's portfolio value fell 18% quarter-over-quarter to $2.07B.

Based on Rice Hall James & Associates's 13F filing for Q2 2022, filed 8 Aug 2022.